Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Liberty Media Series A
FWONA
$23.4B
| $38.2M | 0.02% |
658,690
+260,236
| +65% | +$15.3M |
|
427
Ashland
ASH
$3.34B
| $38.2M | 0.02% |
452,819
+429,332
| +1,828% | +$34M |
|
428
Metallus
MTUS
$833M
| $37.7M | 0.02% |
1,609,420
-32
| -0% | -$671 |
|
429
The Bancorp
TBBK
$2.81B
| $37.5M | 0.02% |
973,134
+6,531
| +0.7% | +$244K |
|
430
Janus International
JBI
$702M
| $37.4M | 0.02% |
2,867,146
+35,284
| +1% | +$375K |
|
431
Bath & Body Works
BBWI
$3.97B
| $37.3M | 0.02% |
865,002
-96,112
| -10% | -$3.25M |
|
432
Meritage Homes
MTH
$4.78B
| $37.1M | 0.02% |
425,568
-3,580
| -0.8% | -$247K |
|
433
Labcorp
LH
$25.2B
| $36.9M | 0.02% |
162,220
-68,779
| -30% | -$14.4M |
|
|
WCN
434
Waste Connections
WCN
$43.6B
| $36.8M | 0.02% |
246,239
-61,005
| -20% | -$8.38M |
|
435
Criteo
CRTO
$1.14B
| $36.1M | 0.02% |
1,426,424
+75,180
| +6% | +$1.95M |
|
|
VRNA
436
DELISTED
Verona Pharma
VRNA
| $35.8M | 0.02% |
1,803,361
+166,539
| +10% | +$2.46M |
|
437
Ball Corp
BALL
$17.5B
| $35.7M | 0.02% |
621,016
+403,597
| +186% | +$20.8M |
|
438
TC Energy
TRP
$70.1B
| $35.7M | 0.02% |
909,564
-77,350
| -8% | -$2.82M |
|
439
BWX Technologies
BWXT
$14.4B
| $35.7M | 0.02% |
464,768
-90,905
| -16% | -$6.99M |
|
440
Cable One
CABO
$237M
| $35.4M | 0.02% |
63,587
-14
| -0% | -$7.99K |
|
441
SkinHealth Systems
SKIN
$83.4M
| $35.1M | 0.02% |
11,299,927
-267,266
| -2% | -$1M |
|
|
AMED
442
DELISTED
Amedisys
AMED
| $35.1M | 0.02% |
369,753
-103,750
| -22% | -$9.69M |
|
|
CLVT.PRA
443
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $35.1M | 0.02% |
955,143
| – | – |
|
|
ITCI
444
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $35M | 0.02% |
489,137
+8,864
| +2% | +$510K |
|
|
UCTT
445
Ultra Clean Holdings
UCTT
$3.12B
| $34.8M | 0.02% |
1,019,030
+98,538
| +11% | +$2.74M |
|
446
Azenta
AZTA
$1.3B
| $34.5M | 0.02% |
529,170
-4,676
| -0.9% | -$254K |
|
447
Atlas Energy Solutions
AESI
$1.27B
| $34.4M | 0.02% |
1,999,288
+16,569
| +0.8% | +$305K |
|
448
Etsy
ETSY
$8.12B
| $34.4M | 0.02% |
424,521
-1,578
| -0.4% | -$113K |
|
449
Canadian Pacific Kansas City
CP
$81B
| $33.9M | 0.02% |
428,597
-543
| -0.1% | -$39.7K |
|
450
Nomad Foods
NOMD
$1.77B
| $33.9M | 0.02% |
1,999,835
+163,028
| +9% | +$2.53M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.